Work

AML-828: Prognostic Impact and Clinical Outcomes of IDH1/IDH2 Mutations in Newly Diagnosed Acute Myeloid Leukemia Treated With Hypomethylating Agents and Venetoclax

Year: 2025

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(25)01734-3

Authors: Jayda Esplund, Sara Leidy, Kenneth Byrd, Heather Male, Tara Lin, Somedeb Ball, Jesus Gonzalez-Lugo, Kateryna Fedorov

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4413782861

Cites:

Cited by:

Related to: 10